Stet Acquisition, Inc. – Trademark Portfolio
Entity Type: 03
Stet Acquisition, Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 7 filings in this category. The portfolio also extends into Class 31 (Natural Agricultural Products) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include WISEARTH. The owner is based in Richardson, TX.
1920 N. Coit Road, Suite 200-313
Richardson, TX 75080
Showing of trademarks Trademarks
Trademark Classifications
Stet Acquisition, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Stet Acquisition, Inc. have?
Stet Acquisition, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 3 registered, 5 abandoned, 2 cancelled.
What trademark classes does Stet Acquisition, Inc. file in?
Stet Acquisition, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Stet Acquisition, Inc.'s most well-known trademarks?
Stet Acquisition, Inc.'s registered trademark portfolio includes well-known marks such as WISEARTH. These are among 3 currently registered trademarks in the portfolio.
What is Stet Acquisition, Inc.'s trademark registration success rate?
Stet Acquisition, Inc. has a 30% trademark registration rate, with 3 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.